anti-Leprecan Like Protein 1 (LEPREL1) Antibodies

Mouse (Murine) Leprecan Like Protein 1 (LEPREL1) interaction partners

1. Altered collagen prolyl 3-hydroxylation is caused by loss of P3H2.

2. prolyl 3-hydroxylation of type IV collagen (show COL4 Antibodies) by P3H2 has an important function preventing maternal platelet aggregation in response to the early developing embryo

3. P3H2 is responsible for the hydroxylation of collagen IV (show COL4 Antibodies), which has the highest 3-hydroxyproline content of all collagens. It is thus possible that P3H2 mutations may lead to a disease with changes in basement membranes.

4. Study found that all 3 mouse Leprecan (show LEPRE1 Antibodies) genes Lepre1 (show LEPRE1 Antibodies), leprel1 and leprel2 (show LEPREL2 Antibodies) are expressed in the notochord; additionally, they are expressed in dorsal root ganglia, limb buds, branchial arches, and developing kidneys.

5. This report characterizes expression of the P3H1 (show LEPRE1 Antibodies), P3H2 and P3H3 (show LEPREL2 Antibodies) genes in embryonic and adult mice.

Human Leprecan Like Protein 1 (LEPREL1) interaction partners

1. Recessive LEPREL1 mutations should be recognized as part of the differential diagnosis of lens subluxation.

2. LEPREL1 plays an important role in eye development and homozygous loss-of-function mutation of this gene can cause severely high myopia and early-onset cataract.

3. mutation in LRPAP1 is associated with high myopia. Further studies are expected to evaluate the pathogenicity of the variants in CTSH, LEPREL1, ZNF644, SLC39A5, and SCO2.

4. High myopia is caused by a mutation in LEPREL1, encoding prolyl 3-hydroxylase 2.

5. P3H2 has preferred substrate sequences among the classes of 3Hyp sites in clade A collagen chains

6. P3H2 is responsible for the hydroxylation of collagen IV (show COL4 Antibodies), which has the highest 3-hydroxyproline content of all collagens. It is thus possible that P3H2 mutations may lead to a disease with changes in basement membranes.

7. The restriction of silencing in P3H2 to breast carcinomas, and its association with oestrogen-receptor-positive cases, suggests that P3H2 may be a breast-cancer-specific tumour suppressor.